The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about many questions as hospitals and blood centers prepare to order the testing. We've put together a FAQ document to clarify what we know today. We will update the document as we get more information on existing questions and as new questions get asked, and will update the blog with the revised FAQ document.
Thanks for your support as we work to rapidly get this testing available to you. You can find the FAQ document here: CTS COVID-19 Questions and Answers
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...